cGAS-mediated IFN-I signaling contributes to disease progression in drug-refractory epilepsy
RNA-seq (gene expression) · mouse · 44 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Mus musculus (mouse)
- Samples
- 44 samples: 5 conditions, mostly with about 8 replicates eachGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE334405_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1474968 and SRA study SRP706912. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 44 samples.
How we read this: 5 replicated groups read from 44 sample titles; they account for 44 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9788115 DVPV_CTX_311 DVPV_CTX
- GSM9788116 DVPV_CTX_324 DVPV_CTX
- GSM9788117 DVPV_CTX_327 DVPV_CTX
- GSM9788118 DVPV_CTX_329 DVPV_CTX
- GSM9788119 DVPV_CTX_330 DVPV_CTX
- GSM9788120 DVPV_CTX_333 DVPV_CTX
- GSM9788121 DVPV_Hipp_311 DVPV_Hipp
- GSM9788122 DVPV_Hipp_324 DVPV_Hipp
- GSM9788123 DVPV_Hipp_327 DVPV_Hipp
- GSM9788124 DVPV_Hipp_329 DVPV_Hipp
- GSM9788125 DVPV_Hipp_330 DVPV_Hipp
- GSM9788126 DVPV_Hipp_333 DVPV_Hipp
- GSM9788127 LG815_C_106 LG815_C
- GSM9788128 LG815_C_121 LG815_C
- GSM9788129 LG815_C_122 LG815_C
- GSM9788130 LG815_C_132 LG815_C
- GSM9788131 LG815_C_139 LG815_C
- GSM9788132 LG815_C_153 LG815_C
- GSM9788133 LG815_C_159 LG815_C
- GSM9788134 LG815_C_164 LG815_C
- GSM9788135 LG815_C_172 LG815_C
- GSM9788136 LG815_C_29 LG815_C
- GSM9788137 LG815_C_30 LG815_C
- GSM9788138 LG815_C_31 LG815_C
- GSM9788139 LG815_C_33 LG815_C
- GSM9788140 LG815_C_35 LG815_C
- GSM9788141 LG815_C_64 LG815_C
- GSM9788142 LG815_C_95 LG815_C
- GSM9788143 LG815_Ctrl_160 LG815_Ctrl
- GSM9788144 LG815_Ctrl_162 LG815_Ctrl
- GSM9788145 LG815_Ctrl_168 LG815_Ctrl
- GSM9788146 LG815_Ctrl_169 LG815_Ctrl
- GSM9788147 LG815_Ctrl_174 LG815_Ctrl
- GSM9788148 LG815_Ctrl_180 LG815_Ctrl
- GSM9788149 LG815_Ctrl_195 LG815_Ctrl
- GSM9788150 LG815_Ctrl_216 LG815_Ctrl
- GSM9788151 LG815_TDI_141 LG815_TDI
- GSM9788152 LG815_TDI_149 LG815_TDI
- GSM9788153 LG815_TDI_152 LG815_TDI
- GSM9788154 LG815_TDI_160 LG815_TDI
+ 4 more — browse all 44 samples with per-sample file links →
- GSE250438 Role of the TRIF-IFN-I pathway in Helicobacter-induced gastric cancer progression in an accelerated murine disease model 19 samples shares ifn-i, progression
- GSE280118 PCK1 loss contributes to kidney disease progression by altering mitochondrial fitness through its cataplerotic function [snRNA-seq_PCK1KI] 4 samples shares contributes, progression
- GSE330626 CXCL10 contributes to female-specific pathological progression in tauopathy model mice 4 samples shares contributes, progression
- GSE337186 IFNg and IFNg mimetics prevent IFN-I-mediated TB susceptibility by regulating iron metabolism and lipid peroxidation. 24 samples shares ifn-i
- GSE276293 Loss of PARP7 increases IFN-I signalling preventing pancreatic tumour growth by enhancing immune cell infiltration 16 samples shares ifn-i
- GSE285244 Metabolic Deficiencies Underlie Reduced Plasmacytoid Dendritic Cell IFN-I Production following Viral Infection [RNA-Seq] 12 samples shares ifn-i
- GSE326459 Slc44a2 deficiency unveils an IFN-I–dependent feedback control of pDC egress 8 samples shares ifn-i
- GSE253771 Free cholesterol primes the IFN-I response by facilitating the release of TLR9 from UNC93B1 6 samples shares ifn-i
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.